An open-label, two-period, multi-center, single dose study to assess the pharmacokinetics of AEB071 in de novo liver transplant patients.
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Sotrastaurin (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Novartis
- 25 Feb 2008 Status changed from recruiting to completed.
- 26 Oct 2007 New trial record.